在可切除非小细胞肺癌中新辅助免疫疗法的当前方法
Jay Parekh1, Kaushal Parikh2, Joshua E Reuss3
1Yale New Haven Health System, Bridgeport Hospital, Bridgeport, CT, USA.
Current oncology reports
|May 30, 2023
概括
新辅助免疫检查点阻塞 (ICB) 显示出对可切除非小细胞肺癌 (NSCLC) 的承诺. 这种方法旨在减少早期NSCLC患者的高复发率,改变治疗模式.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 胸部外科手术 胸部外科手术
背景情况:
- 早期切除的非小细胞肺癌 (NSCLC) 历史上面临着高的复发率,尽管有治疗意图的手术.
- 系统性疗法正在越来越多地被调查在外科手术前设置可切除的NSCLC.
研究的目的:
- 审查新辅助抗PD(L) 1免疫检查点阻塞 (ICB) 在可切除的非小细胞肺癌中的作用.
- 要突出临床前的理由,临床试验数据,以及新辅助ICB用于切除的NSCLC的未来方向.
主要方法:
- 临床前研究和临床试验 (早期阶段和随机阶段3) 的综述,调查可切除的NSCLC中的新辅助ICB.
- 分析ICB对局部和局部晚期NSCLC治疗模式的影响.
主要成果:
- 抗PD(L) 1 ICB已经彻底改变了先进的NSCLC治疗方法,现在正在为切除性疾病在外科外科环境中探索.
- 新辅助性ICB正在成为局部和局部先进NSCLC的转型战略.
结论:
- 新辅助性ICB代表了可切除NSCLC的管理中的重大进步.
- 进一步的研究和临床试验对于优化新辅助ICB在NSCLC中的使用至关重要.
相关概念视频
01:27Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577
01:30Cancer Vaccines
437
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
437